Rigel Pharmaceuticals Newsroom

Rigel Pharmaceuticals Price Target Raised to $25.00/Share From $15.00 by Cantor Fitzgerald

Dow JonesDec 10 09:03 ET

Rigel Pharmaceuticals Is Maintained at Neutral by Cantor Fitzgerald

Dow JonesDec 10 09:03 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaDec 10 07:09 ET

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsDec 10 06:31 ET

B.Riley Financial Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $27

Moomoo NewsDec 6 14:32 ET

B. Riley Adjusts Price Target on Rigel Pharmaceuticals to $27 From $17, Maintains Neutral Rating

MT NewswiresDec 6 09:45 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaNov 12 13:34 ET

Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $49

Moomoo NewsNov 11 15:32 ET

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsNov 8 07:35 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaOct 25 06:57 ET

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsOct 25 06:31 ET

Rigel Pharmaceuticals Price Target Maintained With a $15.00/Share by Cantor Fitzgerald

Dow JonesSep 20 12:40 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaSep 5 14:38 ET

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsSep 3 10:32 ET

HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Adjusts Price Target To $57 (1-20 Reverse Stock Split)

BenzingaAug 9 17:47 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaAug 9 17:45 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaJun 25 07:22 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaJun 17 06:20 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaJun 3 12:34 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaMay 8 09:38 ET